This Article Full Text Full Text (PDF) All Versions of this Article: 97/9/872    most recent 01.RES.0000187458.77026.10v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, J. Articles by Young, L. H. Search for Related Content PubMed PubMed Citation Articles by Li, J. Articles by Young, L. H. Related Collections Biochemistry and metabolism Cell signalling/signal transduction Energy metabolism Ischemic biology - basic studies

(Circulation Research. 2005;97:872.)
© 2005 American Heart Association, Inc.

Molecular Medicine

AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart

Ji Li, Edward J. Miller, Jun Ninomiya-Tsuji, Raymond R. Russell, III, Lawrence H. Young

From the Section of Cardiovascular Medicine (J.L, E.J.M., R.R.R., L.H.Y.), Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn; and the Department of Environmental and Molecular Toxicology (J.N.-T.), North Carolina State University, Raleigh, NC.

Correspondence to Lawrence H. Young, MD, Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06520. E-mail lawrence.young{at}yale.edu

AMP-activated protein kinase (AMPK) promotes glucose transport, maintains ATP stores, and prevents injury and apoptosis during ischemia. AMPK has several direct molecular targets in the heart but also may interact with other stress-signaling pathways. This study examined the role of AMPK in the activation of the p38 mitogen-activated protein kinase (MAPK). In isolated heart muscles, the AMPK activator 5-aminoimidazole-4-carboxy-amide-1-ß-D-ribofuranoside (AICAR) increased p38 MAPK activation. In AMPK-deficient mouse hearts, expressing a kinase-dead (KD) ₂ catalytic subunit, p38 MAPK activation was markedly reduced during low-flow ischemia (2.3- versus 7-fold in wild-type hearts, P<0.01) and was similarly reduced during severe no-flow ischemia in KD hearts (P<0.01 versus ischemic wild type). Knockout of the p38 MAPK upstream kinase, MAPK kinase 3 (MKK3), did not affect ischemic activation of either AMPK or p38 MAPK in transgenic mkk3^–/– mouse hearts. Ischemia increased p38 MAPK recruitment to transforming growth factor-ß-activated protein kinase 1–binding protein 1 (TAB1), a scaffold protein that promotes p38 MAPK autophosphorylation. Moreover, TAB1 was associated with the ₂ catalytic subunit of AMPK. p38 MAPK recruitment to TAB1/AMPK complexes required AMPK activation and was reduced in ischemic AMPK-deficient transgenic mouse hearts. The potential role of p38 MAPK in mediating the downstream action of AMPK to promote glucose transport was also assessed. The p38 MAPK inhibitor SB203580 partially inhibited both AICAR- and hypoxia-stimulated glucose uptake and GLUT4 translocation. Activation of p38 MAPK by anisomycin also increased glucose transport in heart muscles. Thus, AMPK has an important role in promoting p38 MAPK activation in the ischemic heart by inducing p38 MAPK autophosphorylation through interaction with the scaffold protein TAB1.

Key Words: ischemia • AMP-activated protein kinase • p38 MAPK mitogen-activated protein kinase • transforming growth factor-ß–activated protein kinase 1–binding protein 1 • glucose transport

This article has been cited by other articles:

				Q. Li, L. K. Hueckstaedt, and J. Ren The protease inhibitor UCF-101 ameliorates streptozotocin-induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase Exp Physiol, September 1, 2009; 94(9): 984 - 994. [Abstract] [Full Text] [PDF]

				A. M. Bair, P. B. Thippegowda, M. Freichel, N. Cheng, R. D. Ye, S. M. Vogel, Y. Yu, V. Flockerzi, A. B. Malik, and C. Tiruppathi Ca2+ Entry via TRPC Channels Is Necessary for Thrombin-induced NF-{kappa}B Activation in Endothelial Cells through AMP-activated Protein Kinase and Protein Kinase C{delta} J. Biol. Chem., January 2, 2009; 284(1): 563 - 574. [Abstract] [Full Text] [PDF]

				P. Zhang, X. Hu, X. Xu, J. Fassett, G. Zhu, B. Viollet, W. Xu, B. Wiczer, D. A. Bernlohr, R. J. Bache, et al. AMP Activated Protein Kinase-{alpha}2 Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice Hypertension, November 1, 2008; 52(5): 918 - 924. [Abstract] [Full Text] [PDF]

				C. Cao, S. Lu, R. Kivlin, B. Wallin, E. Card, A. Bagdasarian, T. Tamakloe, W.-m. Chu, K.-l. Guan, and Y. Wan AMP-activated Protein Kinase Contributes to UV- and H2O2-induced Apoptosis in Human Skin Keratinocytes J. Biol. Chem., October 24, 2008; 283(43): 28897 - 28908. [Abstract] [Full Text] [PDF]

				G. Kewalramani, P. Puthanveetil, M. S. Kim, F. Wang, V. Lee, N. Hau, E. Beheshti, N. Ng, A. Abrahani, and B. Rodrigues Acute dexamethasone-induced increase in cardiac lipoprotein lipase requires activation of both Akt and stress kinases Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E137 - E147. [Abstract] [Full Text] [PDF]

				S. Jacquet, Y. Nishino, S. Kumphune, P. Sicard, J. E. Clark, K. S. Kobayashi, R. A. Flavell, J. Eickhoff, M. Cotten, and M. S. Marber The Role of RIP2 in p38 MAPK Activation in the Stressed Heart J. Biol. Chem., May 2, 2008; 283(18): 11964 - 11971. [Abstract] [Full Text] [PDF]

				B.-K. Son, M. Akishita, K. Iijima, K. Kozaki, K. Maemura, M. Eto, and Y. Ouchi Adiponectin Antagonizes Stimulatory Effect of Tumor Necrosis Factor-{alpha} on Vascular Smooth Muscle Cell Calcification: Regulation of Growth Arrest-Specific Gene 6-Mediated Survival Pathway by Adenosine 5'-Monophosphate-Activated Protein Kinase Endocrinology, April 1, 2008; 149(4): 1646 - 1653. [Abstract] [Full Text] [PDF]

				C. Segalen, S. L. Longnus, D. Baetz, L. Counillon, and E. Van Obberghen 5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribofuranoside Reduces Glucose Uptake via the Inhibition of Na+/H+ Exchanger 1 in Isolated Rat Ventricular Cardiomyocytes Endocrinology, April 1, 2008; 149(4): 1490 - 1498. [Abstract] [Full Text] [PDF]

				J. W. Calvert, S. Gundewar, S. Jha, J. J.M. Greer, W. H. Bestermann, R. Tian, and D. J. Lefer Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS-Mediated Signaling Diabetes, March 1, 2008; 57(3): 696 - 705. [Abstract] [Full Text] [PDF]

				L. H. Young AMP-Activated Protein Kinase Conducts the Ischemic Stress Response Orchestra Circulation, February 12, 2008; 117(6): 832 - 840. [Full Text] [PDF]

				N. Makeeva, G. M. Roomans, J. W. Myers, and N. Welsh Transforming Growth Factor- -Activated Protein Kinase 1-Binding Protein (TAB)-1{alpha}, But Not TAB1 , Mediates Cytokine-Induced p38 Mitogen-Activated Protein Kinase Phosphorylation and Cell Death in Insulin-Producing Cells Endocrinology, January 1, 2008; 149(1): 302 - 309. [Abstract] [Full Text] [PDF]

				M. S. Kim, G. Kewalramani, P. Puthanveetil, V. Lee, U. Kumar, D. An, A. Abrahani, and B. Rodrigues Acute Diabetes Moderates Trafficking of Cardiac Lipoprotein Lipase Through p38 Mitogen-Activated Protein Kinase Dependent Actin Cytoskeleton Organization Diabetes, January 1, 2008; 57(1): 64 - 76. [Abstract] [Full Text] [PDF]

				S. Jacquet, E. Zarrinpashneh, A. Chavey, A. Ginion, I. Leclerc, B. Viollet, G. A. Rutter, L. Bertrand, and M. S. Marber The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia Cardiovasc Res, December 1, 2007; 76(3): 465 - 472. [Abstract] [Full Text] [PDF]

				J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1107 - H1114. [Abstract] [Full Text] [PDF]

				J. E. Clark, R. A. Flavell, M. E. Faircloth, R. J. Davis, R. J. Heads, and M. S. Marber Post-infarction remodeling is independent of mitogen-activated protein kinase kinase 3 (MKK3) Cardiovasc Res, June 1, 2007; 74(3): 466 - 470. [Abstract] [Full Text] [PDF]

				A. Pelletier and L. Coderre Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1325 - E1332. [Abstract] [Full Text] [PDF]

				J. S. Jaswal, M. Gandhi, B. A. Finegan, J. R. B. Dyck, and A. S. Clanachan p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5'-AMP-activated protein kinase Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1978 - H1985. [Abstract] [Full Text] [PDF]

				T. A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh Adiponectin actions in the cardiovascular system Cardiovasc Res, April 1, 2007; 74(1): 11 - 18. [Abstract] [Full Text] [PDF]

				M. Arad, C. E. Seidman, and J.G. Seidman AMP-Activated Protein Kinase in the Heart: Role During Health and Disease Circ. Res., March 2, 2007; 100(4): 474 - 488. [Abstract] [Full Text] [PDF]

				K. A. Rasbach and R. G. Schnellmann Signaling of Mitochondrial Biogenesis following Oxidant Injury J. Biol. Chem., January 26, 2007; 282(4): 2355 - 2362. [Abstract] [Full Text] [PDF]

				V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF]

				M. Xie, D. Zhang, J. R. B. Dyck, Y. Li, H. Zhang, M. Morishima, D. L. Mann, G. E. Taffet, A. Baldini, D. S. Khoury, et al. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway PNAS, November 14, 2006; 103(46): 17378 - 17383. [Abstract] [Full Text] [PDF]

				J. J. F. P. Luiken, I. Momken, D. D. J. Habets, M. El Hasnaoui, W. A. Coumans, D. P. Y Koonen, J. F. C. Glatz, and A. Bonen Arsenite Modulates Cardiac Substrate Preference by Translocation of GLUT4, But Not CD36, Independent of Mitogen-Activated Protein Kinase Signaling Endocrinology, November 1, 2006; 147(11): 5205 - 5216. [Abstract] [Full Text] [PDF]

				J. Li, D. L. Coven, E. J. Miller, X. Hu, M. E. Young, D. Carling, A. J. Sinusas, and L. H. Young Activation of AMPK {alpha}- and {gamma}-isoform complexes in the intact ischemic rat heart Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1927 - H1934. [Abstract] [Full Text] [PDF]

				M. Momcilovic, S.-P. Hong, and M. Carlson Mammalian TAK1 Activates Snf1 Protein Kinase in Yeast and Phosphorylates AMP-activated Protein Kinase in Vitro J. Biol. Chem., September 1, 2006; 281(35): 25336 - 25343. [Abstract] [Full Text] [PDF]

				J. R. B. Dyck and G. D. Lopaschuk AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol., July 1, 2006; 574(1): 95 - 112. [Abstract] [Full Text] [PDF]

				G. Lu, Y. J. Kang, J. Han, H. R. Herschman, E. Stefani, and Y. Wang TAB-1 Modulates Intracellular Localization of p38 MAP Kinase and Downstream Signaling J. Biol. Chem., March 3, 2006; 281(9): 6087 - 6095. [Abstract] [Full Text] [PDF]